Stay updated on mRNA-4157 Vaccine and Pembrolizumab in Melanoma Clinical Trial.

Sign up to get notified when there's something new on the mRNA-4157 Vaccine and Pembrolizumab in Melanoma Clinical Trial. page.
Latest website image capture
Clouds background image

Latest updates to the mRNA-4157 Vaccine and Pembrolizumab in Melanoma Clinical Trial. page

  1. Check
    5 days ago
    Change Detected
    Summary
    Added Melanoma and related topics, including MedlinePlus Genetics, to the page's related resources. Updated the revision note to Revision: v3.4.3 and removed the previous Revision: v3.4.2.
    Difference
    0.2%
    Check dated 2026-03-11T16:46:43.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    - Removal of key topic keywords 'Melanoma' and the related topics section 'MedlinePlus Genetics' from the page content. This affects how the study's scope is communicated and indexed.
    Difference
    0.1%
    Check dated 2026-03-04T12:24:38.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    - Added Related Topics: Melanoma and MedlinePlus Genetics to the study page to provide supplementary background resources. This does not modify core study content.
    Difference
    0.1%
    Check dated 2026-02-25T08:44:56.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added. The government funding operating-status notice and the Revision: v3.4.1 entry were removed.
    Difference
    0.4%
    Check dated 2026-02-11T02:49:27.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A site-wide operating status notice and a revision update were added, and a few study-related topics/keywords were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-04T00:48:49.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Glossary display and related topic links (Melanoma, MedlinePlus Genetics) were added. Revision and update-related metadata were updated (e.g., Last Update..., No FEAR Act Data, Revision: v3.4.0) and some older update fields were removed.
    Difference
    0.4%
    Check dated 2026-01-27T23:54:35.000Z thumbnail image

Stay in the know with updates to mRNA-4157 Vaccine and Pembrolizumab in Melanoma Clinical Trial.

Enter your email address, and we'll notify you when there's something new on the mRNA-4157 Vaccine and Pembrolizumab in Melanoma Clinical Trial. page.